Evolent Health, valued at $3.3bn, explores potential sale with interest from TPG, CD&R, KKR, and Elevance Health.
Healthcare services provider Evolent Health, valued at $3.3bn, is considering a potential sale following interest from private equity firms TPG, CD&R, and KKR, along with health insurer Elevance Health. Evolent has engaged a financial adviser, and initial bids have been submitted, though a final deal is not certain. Confidential talks are ongoing, and a resolution may be expected in the coming weeks.
August 22, 2024
7 Articles